Chimerix, Inc

(NASDAQ:CMRX)

Latest On Chimerix, Inc (CMRX):

Date/Time Type Description Signal Details
2023-05-22 20:20 ESTNewsChimerix a buy at Baird on late-stage glioma candidateN/A
2023-05-07 02:21 ESTNewsChimerix, Inc. (CMRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 10:40 ESTNewsChimerix GAAP EPS of -$0.24 in-line, revenue of $0.28M beats by $0.15MN/A
2023-03-10 21:47 ESTNewsChimerix says exposure to any SVB liquidity risk is “immaterial”N/A
2023-03-06 12:32 ESTNewsChimerix: Gaining Traction, Cash Runway To 2027N/A
2023-03-02 14:55 ESTNewsChimerix GAAP EPS of -$0.24 in-line, revenue of $0.8M beats by $0.22MN/A
2023-03-02 14:55 ESTNewsChimerix, Inc. (CMRX) Q4 2022 Earnings Call TranscriptN/A
2023-03-02 00:27 ESTNewsChimerix Q4 2022 Earnings PreviewN/A
2022-12-08 23:43 ESTNewsChimerix cuts workforce by 25% to focus on oncology pipelineN/A
2022-11-14 07:09 ESTNewsChimerix: Big Doings At A Small BiotechN/A
2022-11-11 08:04 ESTNewsChimerix rejects calls for liquidation from Rubric Capital ManagementN/A
2022-11-05 10:21 ESTNewsChimerix, Inc. (CMRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 01:06 ESTNewsChimerix GAAP EPS of $2.75 beats by $0.65, revenue of $32.56MN/A
2022-11-04 01:06 ESTNewsChimerix gains on regulatory updates for cancer therapyN/A
2022-11-02 15:26 ESTNewsChimerix Q3 2022 Earnings PreviewN/A
2022-08-30 02:55 ESTNewsChimerix gains 20% on $551M U.S. contract for smallpox therapyN/A
2022-08-24 02:22 ESTNewsChimerix: Advancement For Rare Brain Cancer Drug Targeting Specific MutationN/A
2022-08-24 02:22 ESTNewsChimerix: A Confusing Business Strategy Makes It UnconvincingN/A
2022-08-09 00:34 ESTNewsChimerix GAAP EPS of -$0.27 misses by $0.03, revenue of $0.44M beats by $0.41MN/A
2022-08-09 00:34 ESTNewsChimerix, Inc's (CMRX) CEO Mike Sherman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-06 07:48 ESTNewsChimerix Q2 2022 Earnings PreviewN/A
2022-07-27 17:39 ESTNewsMonkeypox cases surpass 19K worldwide as WHO urges reducing sexual partnersN/A
2022-07-27 17:39 ESTNewsStates to begin sharing data about monkeypox as CDC aims to better understand spreadN/A
2022-07-27 03:56 ESTNewsFeds may need $7B to adequately respond to monkeypox outbreak - WaPoN/A
2022-07-20 20:17 ESTNewsWHO set for second monkeypox meeting as cases soar to more than 14K - ReutersN/A
2022-07-16 17:59 ESTNewsU.S. orders 2.5M more Bavarian Nordic monkeypox vaccine dosesN/A
2022-06-24 23:50 ESTNewsChimerix ticks higher on new order for smallpox therapyN/A
2022-06-23 10:29 ESTNewsChimerix receives $9.3M international procurement agreement for monkeypox treatmentN/A
2022-06-06 18:52 ESTNewsChimerix: Down But Not OutN/A
2022-05-17 05:03 ESTNewsChimerix, Inc. (CMRX) CEO Mike Sherman on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-16 10:19 ESTNewsChimerix GAAP EPS of -$0.28 beats by $0.07, revenue of $0.02M beats by $0.02MN/A
2022-05-16 10:19 ESTNewsChimerix stock slumps ~37% on Emergent acquiring rights to smallpox therapy TembexaN/A
2022-04-14 06:20 ESTNewsChimerix says unusual trading may be due to smallpox antiviral development with HHSN/A
2022-03-01 23:06 ESTNewsChimerix GAAP EPS of -$0.45 misses by $0.28, revenue of $0.05M misses by $18.01MN/A
2022-03-01 23:06 ESTNewsChimerix, Inc. (CMRX) CEO Mike Sherman on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 04:47 ESTNewsChimerix Q4 2021 Earnings PreviewN/A
2022-01-18 19:15 ESTNewsChimerix announces publication of study data for the cancer candidateN/A
2022-01-05 03:02 ESTNewsChimerix: Searching For ClarityN/A
2021-11-30 23:04 ESTNewsChimerix rises after announcing govt. interest in purchasing smallpox drugN/A
2021-11-19 09:50 ESTNewsChimerix announces positive ONC201 data in brain cancerN/A
2021-11-09 06:17 ESTNewsChimerix recovers from last week's post-Q3 earnings plungeN/A
2021-11-06 18:24 ESTNewsChimerix, Inc. (CMRX) CEO Mike Sherman on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-05 03:36 ESTNewsChimerix EPS in-line, misses on revenueN/A
2021-11-05 03:36 ESTNewsChimerix shares slide 27% after Q3 topline miss, cash position updateN/A
2021-11-03 10:17 ESTNewsChimerix Q3 2021 Earnings PreviewN/A
2021-10-12 22:39 ESTNewsWarning: CMRX is at high risk of performing badlyN/A
2021-10-07 07:26 ESTNewsCMRX is at high risk of performing badlyN/A
2021-09-17 16:53 ESTNewsWarning: CMRX has been downgraded to Very Bearish.N/A
2021-08-14 07:51 ESTNewsChimerix, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 10:19 ESTNewsChimerix, Inc. (CMRX) CEO Mike Sherman on Q2 2021 Results - Earnings Call TranscriptN/A

About Chimerix, Inc (CMRX):

Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox; dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy; and ONC201 a program for potentially treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

CMRX Quotes by TradingView

See Advanced Chart

General

  • Name Chimerix, Inc
  • Symbol CMRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 54
  • Fiscal Year EndDecember
  • IPO Date2013-04-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.chimerix.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 115.76
  • Price/Book (Most Recent Quarter) 11.68
  • Enterprise Value Revenue 145.32
  • Enterprise Value EBITDA 0.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.80
  • Next Year EPS Estimate -$0.39
  • Next Quarter EPS Estimate -$0.76
  • Operating Margin -829%
  • Return on Assets -27%
  • Return on Equity -47%
  • Revenue 5.37 million
  • Earnings Per Share -$1.32
  • Revenue Per Share $0.09
  • Gross Profit -30860000
  • Quarterly Earnings Growth -83.4%
View More

Highlights

  • Market Capitalization 819.09 million
  • EBITDA -68996000
  • PE Ratio -0.99
  • Analyst Target Price $13.33
  • Book Value Per Share $1.17
View More

Share Statistics

  • Shares Outstanding 85.68 million
  • Shares Float 74.24 million
  • % Held by Insiders 1834%
  • % Held by Institutions 53.07%
  • Shares Short 975040
  • Shares Short Prior Month 794294
  • Short Ratio 1.32
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.66
  • 52 Week High $11.57
  • 52 Week Low $1.28
  • 50 Day Moving Average 9.88
  • 200 Day Moving Average 5.53
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Chimerix, Inc (CMRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Chimerix, Inc (CMRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.19-$0.190%
2020-09-302020-11-05$1.61 million-$0.18-$0.17-9.09%
2020-06-302020-08-10$N/A-$0.16-$0.188.57%
2020-03-312020-05-07$N/A-$0.17-$0.15-13.33%
2019-12-312020-02-25$6.77 million-$0.06-$0.1764.71%
2019-09-302019-11-05$1.96 million-$1.26-$0.22-486.05%
2019-06-302019-08-08$1.44 million-$0.35-$0.374.11%
2019-03-312019-05-09$2.36 million-$0.35-$0.35-1.45%
2018-12-312019-03-05$4.86 million-$0.29-$0.3619.44%
2018-09-302018-11-08$369000-$0.33-$0.4220.48%
2018-06-302018-08-08$1.19 million-$0.39-$0.4411.66%
2018-03-312018-05-07$790000-$0.42-$0.431.75%
2017-12-312018-03-01$644000-$0.41-$0.4813.78%
2017-09-302017-11-08$897000-$0.37-$0.4313.37%
2017-06-302017-08-07$675000-$0.36-$0.4111.57%
2017-03-312017-05-09$1.08 million-$0.38-$0.36-4.28%
2016-12-312017-03-02$1.98 million-$0.32-$0.3917.12%
2016-09-302016-11-07$653000-$0.37-$0.407.57%
2016-06-302016-08-08$1.84 million-$0.39-$0.5124.08%
2016-03-312016-05-09$1.23 million-$0.57-$0.7018.15%
2015-12-312016-02-29$3.11 million-$0.82-$0.73-12.22%
2015-09-302015-11-05$2.27 million-$0.70-$0.59-18.64%
2015-06-302015-08-06$4.14 million-$0.59-$0.58-1.72%
2015-03-312015-05-11$1.24 million-$0.54-$0.575.26%
2014-12-312015-03-06$1.16 million-$0.52-$0.48-8.33%
2014-09-302014-11-07$1.19 million-$0.47-$0.40-17.5%
2014-06-302014-08-07$919000-$0.39-$0.4411.36%
2014-03-312014-05-09$780000-$0.39-$0.36-8.33%
2013-12-312014-03-07$879000-$0.31-$0.4124.39%
2013-09-302013-11-14$912000-$0.26-$0.3831.58%
2013-06-302013-08-14$808000-$0.91-$0.40-127.5%
2013-03-312013-05-13$1.77 million-$22.58-$2.43-829.22%

Chimerix, Inc (CMRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Chimerix, Inc (CMRX) Chart:

Chimerix, Inc (CMRX) News:

Below you will find a list of latest news for Chimerix, Inc (CMRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Chimerix, Inc (CMRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-01-170.50.5CALL0 80TRUE00
2025-01-1710.1CALL53 193370.79FALSE0.020.25
2025-01-171.50.05CALL0 39100FALSE00
2025-01-1720.05CALL0 5140FALSE00
2025-01-172.50.05CALL0 8050FALSE00
2025-01-1730.1CALL0 90FALSE00
2025-01-173.50.1CALL0 50FALSE00
2025-01-1740.05CALL0 250FALSE00
2025-01-174.50.05CALL0 300FALSE00
2025-01-170.50.1PUT0 240FALSE00
2025-01-1710.15PUT50 99645.13TRUE0.150
2025-01-171.50PUT0 00TRUE00
2025-01-1721.05PUT0 00TRUE00
2025-01-172.50PUT0 00TRUE00
2025-01-1731.9PUT0 00TRUE00
2025-01-173.52.3PUT0 00TRUE00
2025-01-1740PUT0 0328.87TRUE00
2025-01-174.53.3PUT0 00TRUE00
2025-02-2110.1CALL219 47960.87FALSE0.10
2025-02-2120.1CALL0 150FALSE00
2025-02-2130CALL0 00FALSE00
2025-02-2140.15CALL0 110FALSE00
2025-02-2150CALL0 00FALSE00
2025-02-2160.05CALL0 500FALSE00
2025-02-2110.2PUT0 44085.96TRUE00
2025-02-2121.15PUT0 10TRUE00
2025-02-2130PUT0 00TRUE00
2025-02-2140PUT0 0301.56TRUE00
2025-02-2150PUT0 0368.92TRUE00
2025-02-2160PUT0 0268.18TRUE00
2025-05-1610CALL0 00FALSE00
2025-05-1620CALL0 00FALSE00
2025-05-1630CALL0 00FALSE00
2025-05-1640CALL0 00FALSE00
2025-05-1610.25PUT25 069.82TRUE0.250
2025-05-1620PUT0 00TRUE00
2025-05-1630PUT0 00TRUE00
2025-05-1640PUT0 0490.08TRUE00

Latest CMRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$1.445
Jun 13, 2022 7:59 PM EST100$1.445
Jun 13, 2022 7:59 PM EST100$1.445
Jun 13, 2022 7:59 PM EST100$1.445
Jun 13, 2022 7:59 PM EST300$1.445

Chimerix, Inc (CMRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120038385/0001209191-20-038385-index.htm
2020-08-13UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1117480/000000000020007418/0000000000-20-007418-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000021545719003216/0000215457-19-003216-index.htm
2018-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000031506618002329/0000315066-18-002329-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000031506619000929/0000315066-19-000929-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000083423720004673/0000834237-20-004673-index.htm
2019-08-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000089924319021086/0000899243-19-021086-index.htm
2019-08-073/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000089924319021199/0000899243-19-021199-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000110465920021814/0001104659-20-021814-index.htm
2020-08-10S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1117480/000110465920092833/0001104659-20-092833-index.htm
2020-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1117480/000110465920094619/0001104659-20-094619-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748018000028/0001117480-18-000028-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1117480/000111748018000029/0001117480-18-000029-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748018000031/0001117480-18-000031-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748018000035/0001117480-18-000035-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1117480/000111748018000036/0001117480-18-000036-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000002/0001117480-19-000002-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000004/0001117480-19-000004-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000008/0001117480-19-000008-index.htm
2019-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1117480/000111748019000010/0001117480-19-000010-index.htm
2019-03-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000011/0001117480-19-000011-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000014/0001117480-19-000014-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000018/0001117480-19-000018-index.htm
2019-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000019/0001117480-19-000019-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000022/0001117480-19-000022-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1117480/000111748019000023/0001117480-19-000023-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000025/0001117480-19-000025-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000027/0001117480-19-000027-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000029/0001117480-19-000029-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000032/0001117480-19-000032-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1117480/000111748019000033/0001117480-19-000033-index.htm
2019-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000036/0001117480-19-000036-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000038/0001117480-19-000038-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748019000042/0001117480-19-000042-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1117480/000111748019000044/0001117480-19-000044-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000002/0001117480-20-000002-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000005/0001117480-20-000005-index.htm
2020-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1117480/000111748020000006/0001117480-20-000006-index.htm
2020-02-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000008/0001117480-20-000008-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000011/0001117480-20-000011-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000013/0001117480-20-000013-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000017/0001117480-20-000017-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000018/0001117480-20-000018-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000021/0001117480-20-000021-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1117480/000111748020000022/0001117480-20-000022-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000024/0001117480-20-000024-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000026/0001117480-20-000026-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1117480/000111748020000028/0001117480-20-000028-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000111748020000031/0001117480-20-000031-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1117480/000111748020000032/0001117480-20-000032-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000114420419005137/0001144204-19-005137-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000114420419008069/0001144204-19-008069-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000114420419013146/0001144204-19-013146-index.htm
2019-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000114420419018944/0001144204-19-018944-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1117480/000114420419036752/0001144204-19-036752-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000117266119000547/0001172661-19-000547-index.htm
2019-04-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000117266119001040/0001172661-19-001040-index.htm
2019-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000117266119002407/0001172661-19-002407-index.htm
2019-08-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000119312519214053/0001193125-19-214053-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919118039004/0001209191-18-039004-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919118039005/0001209191-18-039005-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919118039006/0001209191-18-039006-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119005356/0001209191-19-005356-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119005359/0001209191-19-005359-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119005361/0001209191-19-005361-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119005994/0001209191-19-005994-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119005995/0001209191-19-005995-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119008275/0001209191-19-008275-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119008276/0001209191-19-008276-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119008277/0001209191-19-008277-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119008279/0001209191-19-008279-index.htm
2019-04-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119024155/0001209191-19-024155-index.htm
2019-04-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119024159/0001209191-19-024159-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119024161/0001209191-19-024161-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119024163/0001209191-19-024163-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119029414/0001209191-19-029414-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119031416/0001209191-19-031416-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119031951/0001209191-19-031951-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119032129/0001209191-19-032129-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119033140/0001209191-19-033140-index.htm
2019-06-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038716/0001209191-19-038716-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038717/0001209191-19-038717-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038718/0001209191-19-038718-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038719/0001209191-19-038719-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038721/0001209191-19-038721-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038722/0001209191-19-038722-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038723/0001209191-19-038723-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038725/0001209191-19-038725-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038727/0001209191-19-038727-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119038728/0001209191-19-038728-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119043295/0001209191-19-043295-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119051063/0001209191-19-051063-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119055525/0001209191-19-055525-index.htm
2019-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119055615/0001209191-19-055615-index.htm
2019-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919119056337/0001209191-19-056337-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120002630/0001209191-20-002630-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120004684/0001209191-20-004684-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120004688/0001209191-20-004688-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120004690/0001209191-20-004690-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120004692/0001209191-20-004692-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120008293/0001209191-20-008293-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120008297/0001209191-20-008297-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120012644/0001209191-20-012644-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120012650/0001209191-20-012650-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120019132/0001209191-20-019132-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120019140/0001209191-20-019140-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120019489/0001209191-20-019489-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120036521/0001209191-20-036521-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120036522/0001209191-20-036522-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120036523/0001209191-20-036523-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120036525/0001209191-20-036525-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120036526/0001209191-20-036526-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120036527/0001209191-20-036527-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120036529/0001209191-20-036529-index.htm
2020-06-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120038383/0001209191-20-038383-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120038385/0001209191-20-038385-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120046206/0001209191-20-046206-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120047570/0001209191-20-047570-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000120919120053071/0001209191-20-053071-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000125889719000969/0001258897-19-000969-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000125889720000868/0001258897-20-000868-index.htm
2020-08-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1117480/000149315220016518/0001493152-20-016518-index.htm
2019-07-31DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1117480/000156761919015537/0001567619-19-015537-index.htm
2020-08-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1117480/999999999520002176/9999999995-20-002176-index.htm
2018-08-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999718007365/9999999997-18-007365-index.htm
2019-02-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999719000593/9999999997-19-000593-index.htm
2019-03-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999719001263/9999999997-19-001263-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999719003537/9999999997-19-003537-index.htm
2019-08-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999719006373/9999999997-19-006373-index.htm
2019-11-08CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999719007507/9999999997-19-007507-index.htm
2020-03-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999720001137/9999999997-20-001137-index.htm
2020-03-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999720001138/9999999997-20-001138-index.htm
2020-09-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1117480/999999999720004845/9999999997-20-004845-index.htm

Chimerix, Inc (CMRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chimerix, Inc (CMRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1834%
Institutional Ownership: 5307%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-04MARTHA J DEMSKIDirectorSell5,000.003.2516,250.000.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm
2020-08-05MARTHA J DEMSKIDirectorSell2,500.003.278,187.250.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm
2020-08-06MARTHA J DEMSKIDirectorSell2,500.003.298,223.750.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm
2020-08-07MARTHA J DEMSKIDirectorSell2,500.003.258,125.000.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm
2020-08-10MARTHA J DEMSKIDirectorSell1,584.003.255,148.480.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120046206/0001209191-20-046206-index.htm
2019-11-06Robert J. MeyerDirectorBuy10,000.001.5815,797.0010,000.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119055525/0001209191-19-055525-index.htm
2019-11-06Michael T. AndrioleChief Business OfficerBuy100,000.001.56156,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119055615/0001209191-19-055615-index.htm
2020-03-12Michael A. ShermanChief Executive OfficerBuy72,995.001.45105,652.96102,995.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120019140/0001209191-20-019140-index.htm
2019-11-11FRED A MIDDLETONDirectorBuy20,000.001.6633,190.00117,523.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119056337/0001209191-19-056337-index.htm
2020-08-19Robert J. MeyerDirectorBuy3,500.002.9210,220.0013,500.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120047570/0001209191-20-047570-index.htm
2019-11-13FRED A MIDDLETONDirectorBuy30,000.001.8254,567.00147,523.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119056337/0001209191-19-056337-index.htm
2020-03-16Michael T. AndrioleChief Business OfficerBuy33,300.001.4347,522.43149,729.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120019489/0001209191-20-019489-index.htm
2019-02-05Michael Albert AlrutzPrincipal Executive OfficerBuy100,000.00156,645.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119008276/0001209191-19-008276-index.htm
2020-08-10MARTHA J DEMSKIDirectorBuy1,584.003.165,005.441,584.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120046206/0001209191-20-046206-index.htm
2020-03-12FRED A MIDDLETONDirectorBuy50,000.001.4069,900.00197,523.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120019132/0001209191-20-019132-index.htm
2019-02-05Timothy W. TrostSVP, CFO & SecretaryBuy100,000.00214,530.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119008279/0001209191-19-008279-index.htm
2019-01-23Garrett NicholsChief Medical OfficerBuy125,000.00215,471.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119005359/0001209191-19-005359-index.htm
2020-08-05MARTHA J DEMSKIDirectorBuy2,500.003.167,900.002,500.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm
2020-08-06MARTHA J DEMSKIDirectorBuy2,500.003.167,900.002,500.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm
2020-08-07MARTHA J DEMSKIDirectorBuy2,500.003.167,900.002,500.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm
2020-02-10Garrett NicholsChief Medical OfficerSell8,805.001.6814,830.26260,066.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120008297/0001209191-20-008297-index.htm
2020-02-07Garrett NicholsChief Medical OfficerSell2,550.001.704,335.00268,871.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120008297/0001209191-20-008297-index.htm
2020-01-07Garrett NicholsChief Medical OfficerSell30,680.002.1566,044.84271,421.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120002630/0001209191-20-002630-index.htm
2019-05-20Michael A. ShermanChief Executive OfficerBuy30,000.003.48104,316.0030,000.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119031416/0001209191-19-031416-index.htm
2019-02-05Garrett NicholsChief Medical OfficerBuy100,000.00312,376.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119008277/0001209191-19-008277-index.htm
2019-05-28MARTHA J DEMSKIDirectorBuy18,000.003.6064,800.0037,013.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119033140/0001209191-19-033140-index.htm
2020-08-04MARTHA J DEMSKIDirectorBuy5,000.003.1615,800.005,000.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm
2019-09-26David JakemanPrincipal Accounting OfficerBuy56,000.0076,006.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119051063/0001209191-19-051063-index.htm
2020-10-02David JakemanPrincipal Accounting OfficerSell4,270.002.4810,589.6085,117.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120053071/0001209191-20-053071-index.htm
2020-02-07David JakemanPrincipal Accounting OfficerSell2,290.001.703,893.0087,876.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120008293/0001209191-20-008293-index.htm
2020-01-21David JakemanPrincipal Accounting OfficerBuy14,160.0090,166.00https://www.sec.gov/Archives/edgar/data/1117480/000120919120004684/0001209191-20-004684-index.htm
2019-05-10FRED A MIDDLETONDirectorBuy30,000.002.9287,678.0097,523.00https://www.sec.gov/Archives/edgar/data/1117480/000120919119029414/0001209191-19-029414-index.htm